central bank digital currency china Top snippets

Defender said that Li Tie had not decided whether to appeal, and Li Tie's defender was interviewed by CCTV reporters outside the court. Regarding the first-instance judgment that Li Tie was sentenced to 20 years, the defender said that Li Tie had not decided whether to appeal, and he would negotiate with Li Tie again. Regarding the state of Li Tie's trial today, the defender's answer is: calm, peaceful and stable. (Tiantian Sports)[The yield of 30-year treasury bonds fell below the 2% mark, and the active bonds of 30-year treasury bonds fell below 2% by 4.26bp, reaching 1.9999% as of press time.Pan Xuan, Beijing Local Financial Administration: The total investable assets of households in Beijing's wealth management market are about 16 trillion yuan. Pan Xuan, deputy director of Beijing Local Financial Administration, pointed out in the global wealth management forum today that Beijing's wealth management industry has good basic conditions, huge market potential and strong demand, and has unique advantages in developing wealth management industry. Among them, on the supply side, the asset management scale of institutions such as bank wealth management, insurance asset management, Public Offering of Fund, private equity funds, trusts and brokerage asset management in Beijing exceeds 30 trillion yuan, accounting for nearly 30% of the country; At the same time, the scale of private equity and venture capital management is also the first in the country. On the demand side, the total investable assets of households in Beijing are about 16 trillion yuan, and the number of high-net-worth families, ultra-high-net-worth families and international ultra-high-net-worth families ranks first in the country.

Asia-Pacific Pharmaceuticals: The new specifications of cefmetazole sodium for injection were approved, and Asia-Pacific Pharmaceuticals announced that the company was approved by National Medical Products Administration, and the new specifications of cefmetazole sodium for injection were 0.5g and 2g, which further enriched the product categories on the basis of the original 1g specifications. The annual sales income of this drug in 2023 was 96.3946 million yuan, accounting for 22.92% of the company's operating income. New specifications are helpful to market promotion and competitiveness improvement, but drug production and sales are affected by policies and market environment, and there are uncertainties.Today, Shengguang Group bought 170 million yuan and sold 171 million yuan at the daily limit, with a turnover of 6.558 billion yuan and a turnover rate of 3.239%. After-hours data show that the special seats of Shenzhen Stock Connect bought 170 million yuan and sold 171 million yuan.The merger of Guotai Junan Haitong Securities was approved by the shareholders' meeting, and the merger and reorganization of Guotai Junan and Haitong Securities completed a key step. On the evening of December 13, the two companies simultaneously announced the resolutions of the shareholders' meeting. The merger and reorganization transaction plan and other related proposals were reviewed by the shareholders' meeting and passed by high votes. The merger and reorganization of Guotai Junan and Haitong Securities is the first merger and reorganization of head brokers since the implementation of the new "National Nine Articles". It is also the largest A+H bilateral market merger and the largest integration case of listed brokers in the history of China capital market, and the largest M&A project in international investment banking since 2008, involving multi-business licenses and a number of domestic and foreign listed subsidiaries.

Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.Huawei and Shenzhen Jiaotong University released the pioneer scene of commercial operation of Shenzhen intelligent network connection. Shenzhen Jiaotong University built the first supporting platform in China. It was learned from Huawei's business officer Wei that during the 2024 academic annual meeting of China Highway Society, in the sub-forum of "Lu Yun Energy" collaborative development, Huawei, Shenzhen Jiaotong University (301091), Shenzhen Intelligent Network Connection Transportation Association and other units jointly released the pioneer scene plan of commercial operation of Shenzhen intelligent network connection smart parking, which helped the integrated and coordinated development of mopeds and Lu Yun. Relying on Huawei's high-precision visual positioning, 5G and AI technologies, Shenzhen Intelligent Networked Collaborative Smart Parking Commercial Operation Pioneer Scenario Scheme has launched a collaborative smart parking scheme combining cars and parking lots, which can provide navigation services and AR reverse car search services for ordinary vehicles. It is reported that commissioned by the government and built by Shenzhen Stock Exchange, relying on the city's digital twin platform and collecting the total traffic data of networked vehicles, the country's first intelligent networked vehicle full chain management and service support platform has been built to support the full-cycle full chain business management of intelligent networked vehicles such as testing, demonstration, access, grading, road operation and commercial operation, and support the cross-departmental collaborative supervision of intelligent networked vehicles.Shanghai Gold Exchange: the settlement price of NYAuTN12 contract in Shanghai New Zealand was 627.85 yuan/gram. On December 13th, Shanghai Gold Exchange issued a notice saying that NYAuTN12 contract in Shanghai New Zealand was settled on December 13th, 2024. The details of the settlement of the contract are as follows: the settlement price of NYAuTN12 contract in Shanghai New Zealand was 627.85 yuan/gram.